This scenario parallels the mechanism of the antiproliferative role of DYRK1A in acute myeloid leukemia (AML) cells, where DYRK1A overexpression accelerates c-MYC degradation without affecting mRNA levels [50]. Here, MYC is linked to acute myeloid leukemia.